Palvella Therapeutics PVLA
NASDAQ PVLA
$132.47 -0.26 (-0.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

Palvella Therapeutics (PVLA) Price to Earnings (2023 - 2024)

Updated

Palvella Therapeutics' (PVLA) Price to Earnings was 0.89 for Q3 2024, up 42.7% from the prior quarter.

Analysis

Palvella Therapeutics (PVLA) Price to Earnings (2023 - 2024) Analysis & Trends

For FY2023, Price to Earnings at Palvella Therapeutics was 80.41.

  • Five-year quarterly Price to Earnings spans a low of 0.62 in Q2 2024 and a high of 77.07 in Q4 2023.
  • Per Business Quant data, the three quarters before Q3 2024 came in at 0.62 (Q2 2024), 0.66 (Q1 2024) and 77.07 (Q4 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Palvella Therapeutics 1.91 Bn 1.66 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 0.89
Jun 30, 2024 0.62
Mar 31, 2024 0.66
Dec 31, 2023 77.07
API Access

Palvella Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=PVLA&period=max&api_key=YOUR_API_KEY